Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review
Authors
Keywords
-
Journal
Journal of Diabetes
Volume 9, Issue 5, Pages 482-494
Publisher
Wiley
Online
2016-06-06
DOI
10.1111/1753-0407.12435
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of metformin and risk of kidney cancer in patients with type 2 diabetes
- (2016) Chin-Hsiao Tseng EUROPEAN JOURNAL OF CANCER
- Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study
- (2016) Laurent Azoulay et al. BMJ-British Medical Journal
- Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study
- (2016) Laurent Azoulay et al. BMJ-British Medical Journal
- No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study
- (2015) Claudia Becker et al. BMC CANCER
- New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications and risk of pancreatic cancer
- (2015) Yunxia Lu et al. BRITISH JOURNAL OF CANCER
- Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients
- (2015) Maria E. Goossens et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus
- (2015) Chin-Hsiao Tseng DIABETES-METABOLISM RESEARCH AND REVIEWS
- Metformin and the risk of endometrial cancer: A population-based cohort study
- (2015) Emily M. Ko et al. GYNECOLOGIC ONCOLOGY
- No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK
- (2015) Bernd Kowall et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes
- (2014) Alice PS Kong et al. BMC Medicine
- Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
- (2014) Ronac Mamtani et al. DIABETES CARE
- Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
- (2014) Konstantinos K. Tsilidis et al. DIABETES CARE
- Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study
- (2014) M. Gokhale et al. DIABETES OBESITY & METABOLISM
- Metformin and the risk of head and neck cancer: a case-control analysis
- (2014) C. Becker et al. DIABETES OBESITY & METABOLISM
- Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis
- (2014) Shinan Yin et al. Diagnostic Pathology
- Metformin Reduces Thyroid Cancer Risk in Taiwanese Patients with Type 2 Diabetes
- (2014) Chin-Hsiao Tseng PLoS One
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Antidiabetic Medications and the Risk of Colorectal Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysis
- (2013) S. Singh et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus
- (2013) G. E. C. Sun et al. DIABETES OBESITY & METABOLISM
- Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes
- (2013) Craig J. Currie et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
- (2013) Bindiya Thakkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Sulfonylureas on Tumor Growth: A Review of the Literature
- (2013) G. Pasello et al. ONCOLOGIST
- Diabetes, antihyperglycemic medications and cancer risk
- (2013) Emily J. Gallagher et al. Current Opinion in Endocrinology Diabetes and Obesity
- Latest insights into the risk of cancer in diabetes
- (2013) Hiroshi Noto et al. Journal of Diabetes Investigation
- Use of Antidiabetic Agents and the Risk of Pancreatic Cancer: A Case–Control Analysis
- (2012) Michael Bodmer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan
- (2012) Kao-Chi Cheng et al. BMC GASTROENTEROLOGY
- Use of Metformin Is Not Associated with a Decreased Risk of Colorectal Cancer: A Case-Control Analysis
- (2012) M. Bodmer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Insulin use and cancer risk in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies
- (2012) I.N. Colmers et al. DIABETES & METABOLISM
- Statin Use as a Moderator of Metformin Effect on Risk for Prostate Cancer Among Type 2 Diabetic Patients
- (2012) D. M. Lehman et al. DIABETES CARE
- Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency
- (2012) J. C. Arjona Ferreira et al. DIABETES CARE
- Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus
- (2012) H. Qiu et al. DIABETES OBESITY & METABOLISM
- Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
- (2012) A. Neumann et al. DIABETOLOGIA
- The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
- (2012) Ming-Chia Hsieh et al. Experimental Diabetes Research
- What Next after Metformin? A Retrospective Evaluation of the Outcome of Second-Line, Glucose-Lowering Therapies in People with Type 2 Diabetes
- (2012) Christopher Ll. Morgan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
- (2012) Chia-Hsuin Chang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study
- (2012) Ronac Mamtani et al. JNCI-Journal of the National Cancer Institute
- Metformin does not alter the risk of lung cancer: A case–control analysis
- (2012) Michael Bodmer et al. LUNG CANCER
- Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
- (2012) D. Soranna et al. ONCOLOGIST
- Thyroid Cancer Risk Is Not Increased in Diabetic Patients
- (2012) Chin-Hsiao Tseng PLoS One
- Diabetes and Risk of Prostate Cancer: A study using the National Health Insurance
- (2011) C.-H. Tseng DIABETES CARE
- Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
- (2011) A. Ferrara et al. DIABETES CARE
- Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study
- (2011) R. Ruiter et al. DIABETES CARE
- Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
- (2011) T. P. van Staa et al. DIABETOLOGIA
- Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
- (2011) C.-H. Tseng DIABETOLOGIA
- Use of metformin and the risk of ovarian cancer: A case–control analysis
- (2011) Michael Bodmer et al. GYNECOLOGIC ONCOLOGY
- Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study
- (2011) Andreas E. Buchs et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
- (2010) Manal M. Hassan et al. CANCER
- Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
- (2010) M. Monami et al. DIABETES CARE
- Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
- (2010) M. Bodmer et al. DIABETES CARE
- Use of sulphonylurea and cancer in type 2 diabetes—The Hong Kong Diabetes Registry
- (2010) Xilin Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
- (2010) Valter Donadon et al. LIVER INTERNATIONAL
- Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study
- (2009) Jonathan L. Wright et al. CANCER CAUSES & CONTROL
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection
- (2009) Takumi Kawaguchi et al. LIVER INTERNATIONAL
- Sulphonylureas and cancer: a case–control study
- (2008) Matteo Monami et al. ACTA DIABETOLOGICA
- In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM)
- (2008) Agnieszka Sliwinska et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
- (2008) J. C. N. Chan et al. DIABETES OBESITY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started